| cisplatin / Generic mfg. |
NCT00909402: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas |
|
|
| Completed | 1b | 39 | US, Canada, Europe | BMS-833923, Cisplatin, Platinol-AQ, Capecitabine, Xeloda | Bristol-Myers Squibb, Exelixis | Stomach Neoplasms, Esophageal Neoplasms | 11/12 | 11/12 | | |
NCT00001332: Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis |
|
|
| Completed | 1 | 50 | US | CHPP with cisplatin | National Cancer Institute (NCI) | Peritoneal Neoplasms, Stomach Neoplasms | | 10/00 | | |
NCT00003157: Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach |
|
|
| Completed | 1 | 26 | US | cisplatin, gemcitabine hydrochloride, radiation therapy | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Gastric Cancer, Pancreatic Cancer | 05/03 | 05/03 | | |
NCT00215514: Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma |
|
|
| Completed | 1 | 25 | US | Epirubicin, Cisplatin, 5-Fluorouracil (5-FU), Radiation | Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital | Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer | 11/03 | 07/14 | | |
NCT00005638: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer |
|
|
| Completed | 1 | | US | cisplatin, irinotecan hydrochloride, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 04/04 | 04/04 | | |
NCT00072332: Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors |
|
|
| Completed | 1 | | US | cisplatin, edotecarin | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 12/05 | 12/09 | | |
EMD 72000-024, NCT00113581: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer |
|
|
| Completed | 1 | 26 | Europe | EMD 72000 (matuzumab) + ECX | Merck KGaA, Darmstadt, Germany | Esophageal Cancer, Gastric Cancer | 05/06 | 01/07 | | |
NCT00553696: Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer |
|
|
| Completed | 1 | 27 | Japan | Cisplatin, S-1, Sunitinib | Pfizer | Stomach Neoplasms | 07/09 | 03/14 | | |
NCT00555672: Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer |
|
|
| Completed | 1 | 34 | Europe | 5-fluorouracil, cisplatin, sunitinib malate | Pfizer | Stomach Neoplasms | 12/09 | 08/10 | | |
|
NCT00842244: Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer |
|
|
| Completed | 1 | 22 | Japan, RoW | axitinib, capecitabine, cisplatin | Pfizer | Stomach Neoplasms, Advanced Gastric Cancer | 12/09 | 10/12 | | |
NCT00960349: Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients |
|
|
| Completed | 1 | 14 | Japan | Cediranib, Cisplatin, Randa, Briplatin,, S-1, TS-1, Randa, Briplatin, Capecitabine, Xeloda | AstraZeneca | Gastric Cancer | 01/10 | 03/11 | | |
|
NCT00555620: Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer |
|
|
| Completed | 1 | 76 | RoW | capecitabine, oxaliplatin, sunitinib malate, Sutent, cisplatin | Pfizer | Stomach Neoplasms | 08/10 | 12/11 | | |
|
NCT00601510: Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer |
|
|
| Completed | 1 | 38 | Europe | capecitabine, cisplatin, imatinib mesylate | Technische Universität München | Gastric Cancer | 01/11 | 01/12 | | |
NCT01269255: A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer |
|
|
| Completed | 1 | 6 | RoW | TS-1 with Cisplatin | Yonsei University | Gastric Cancer | 01/12 | 01/12 | | |
NCT01791374: Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ |
|
|
| Completed | 1 | 21 | Japan | Rilotumumab, AMG 102 | Amgen | Part 1- Advanced Solid Tumors, Part 2- Advanced or Metastatic Gastric Cancer, Part 2- Advanced or Metastatic GEJ | 08/13 | 03/15 | | |
|
|
NCT02024841: Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis |
|
|
| Completed | 1 | 12 | RoW | Intraperitoneal docetaxel, Intraperitoneal taxotere | The University of Hong Kong, Taiho Pharmaceutical Co., Ltd. | Gastric Cancer, Peritoneal Carcinomatosis | 02/17 | 03/18 | | |
